Agency Forms Undergoing Paperwork Reduction Act Review, 12738-12739 [E8-4650]
Download as PDF
<![CDATA[
12738
Federal Register / Vol. 73, No. 47 / Monday, March 10, 2008 / Notices
• Delete the title and statement for
Division of User Liaison and Research
Translation (END) in its entirety.
These changes are effective upon the
date of the Director of AHRQ’s
signature.
Dated: February 28, 2008.
Carolyn M. Clancy,
AHRQ Director.
[FR Doc. E8–4458 Filed 3–7–08; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–08–0692]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–6974. Written
comments should be received within 30
days of this notice.
Notice of Correction to Burden Table
Proposed Project
A Survey of the Knowledge, Attitudes
and Practice of Medical and Allied
Health Professionals Regarding Fetal
Alcohol Exposure—Revision—National
Center on Birth Defects and
Developmental Disabilities (NCBDDD),
Centers for Disease Control and
Prevention (CDC).
Description of Correction
The previous 30-day Federal Registrar
(FRN) published January 25, 2008,
Volume 73, No. 17, Pages 4575–4576,
was submitted with an error showing
five previously approved forms. This
notice is corrected to show only the
requested number of burden hours to
continue this project.
Background and Brief Description
Maternal prenatal alcohol use is one
of the leading, preventable, causes of
birth defects and developmental
disabilities. Children exposed to alcohol
during fetal development can suffer a
wide array of disorders, from subtle
changes in I.Q. and behaviors to
profound mental retardation. These
conditions are known as fetal alcohol
spectrum disorders (FASDs). The most
severe condition within the spectrum is
fetal alcohol syndrome (FAS), which
involves disorders of the brain, growth
retardation, and facial malformations.
Physicians and other health
practitioners play a vital role in
diagnosing FAS and in screening
women of child-bearing age for alcohol
consumption and drinking during
pregnancy. In Diekman’s, et al. (2000)
study of obstetricians and gynecologists,
only one fifth of doctors surveyed
reported abstinence to be the safest way
to avoid the adverse outcomes
associated with fetal alcohol exposure.
Importantly, 13% of doctors surveyed
were not sure of levels of alcohol
consumption associated with adverse
outcomes. One of CDC’s multifaceted
initiatives in combating alcohol-exposed
pregnancies is the education and
reeducation of medical and allied health
students and practitioners.
In fiscal year 2002, the Centers for
Disease Control and Prevention (CDC)
received a congressional mandate to
develop guidelines for the diagnosis of
FAS and other conditions resulting from
prenatal alcohol exposure; and to
incorporate these guidelines into
curricula for medical and allied health
students and practitioners [Public
Health Service Act Section 317K (247b–
12) b and c].
In response to the second
congressional mandate listed above,
CDC proposed five national surveys of
health providers. In August of 2005,
OMB approved these five surveys under
control number 0920–0692. The
purposes of the surveys are to assess,
among various health care provider
groups, their knowledge, attitudes, and
practices regarding the prevention,
identification, and treatment of FASDs.
These health care provider groups are
pediatricians, obstetrician-gynecologists
(OB-GYNs), psychiatrists, family
physicians, and allied health
professionals.
The results of the surveys will help to
inform further development of model
FASD curricula to disseminate among
medical and allied health students and
professionals nation wide using a
variety of formats including computer
interactive learning applications,
workshops and conferences, Continuing
Medical Education credit courses, and
medical and allied health school grand
rounds and clerkships. Consistent with
OMB’s previous terms of clearance, CDC
does not expect the results to be
generalizable to the larger populations
of the professional organizations from
which the samples were drawn. Instead,
the survey results will provide
necessary information to further
develop and refine educational
materials for medical and allied health
students and practitioners and to
evaluate their effectiveness. No gifts or
compensation will be given to
respondents who complete the survey.
An average of one survey per year will
be conducted.
There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
375.
ESTIMATED ANNUALIZED BURDEN
No. of
respondents
Type of respondent
pwalker on PROD1PC71 with NOTICES
Selected Survey Instrument ................................................................................
VerDate Aug<31>2005
16:39 Mar 07, 2008
Jkt 214001
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
No. of responses
per respondent
900
E:\FR\FM\10MRN1.SGM
1
10MRN1
Average burden per
response
(in hours)
25/60
12739
Federal Register / Vol. 73, No. 47 / Monday, March 10, 2008 / Notices
Dated: February 29, 2008.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E8–4650 Filed 3–7–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60 Day–08–08AS]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Maryam I. Daneshvar,
CDC Acting Reports Clearance Officer,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Surveys of BioSense Trainings,—
New—National Center for Public Health
Informatics (NCPHI), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Congress passed the Public Health
Security and Bioterrorism Preparedness
and Response Act of 2002, which
requires specific activities related to
bioterrorism preparedness and response.
This congressional mandate outlines the
need for improving the overall public’s
health through electronic surveillance.
The Department of Health and Human
Services outlined strategies aimed at
achieving this goal via the Public Health
IT Initiative thereby creating the
BioSense program.
BioSense is the national, human
health surveillance system designed to
improve the nation’s capabilities for
disease detection, monitoring, and realtime health situational awareness. This
work is enhanced by providing public
health real-time access to existing data
from healthcare organizations, state
syndromic surveillance systems,
national laboratories, and others for just
in time public health decision-making.
BioSense data are analyzed through
advanced statistical methods, and made
accessible through the BioSense
application. The application provides
data, charts, graphs, and maps through
a secure web-based interface which can
be accessed by CDC and authorized state
and local public health and hospital
users.
In order to meet the congressional
mandate, it is important that BioSense
users understand the role of BioSense in
daily surveillance as well as be able to
use specific BioSense modalities to
investigate or monitor any potential
disease outbreaks and/or bioterrorist
attacks. A series of training tools have
been developed to educate BioSense
users about how best to utilize BioSense
in these circumstances.
The training tools were developed
based upon a 2007 needs assessment
conducted among BioSense users.
Training 1 is an online, self-paced
training module designed for BioSense
users at the beginner level who are not
wholly familiar with BioSense or have
not used the system on a regular basis.
This module presents the background of
BioSense and an overview of its general
functions in a didactic training style.
Training 2 is a virtual training filmed in
Second Life. It is designed for
intermediate to advanced level users
who are aware of and have used the
general BioSense functionalities for
daily surveillance but want additional
skills related to using BioSense during
an emergency scenario. This scenariobased module is presented in an
experiential training style.
Data collection will take place in the
form of an online survey immediately
following each training module and a
link to an online survey emailed 3months post training. This data
collection will assess the goals of these
trainings, which are to help registered
BioSense users (1) establish knowledge
and efficacy necessary to use BioSense
to investigate and/or monitor a potential
event or outbreak; (2) facilitate
communication between BioSense
administrators in public health and
hospital settings; (3) access BioSense
trainings that are engaging and easy to
use; and (4) use BioSense to investigate
and/or monitor a potential event or
outbreak. The post-training and 3-month
follow-up surveys have been pre-tested
with less than 9 participants. Survey
results will be used to identify the
impact and applicability of these
training modules for BioSense users.
There are no costs to survey
respondents other than their time to
participate.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form
Number of
responses per
respondent
Average burden
per response
(in hours)
Total burden
(in hours)
400
320
1
1
10/60
5/60
67
27
Total ..................................................................................
pwalker on PROD1PC71 with NOTICES
Post-Training Survey ...............................................................
3–Month Follow Up Survey .....................................................
..............................
..............................
..............................
94
VerDate Aug<31>2005
16:39 Mar 07, 2008
Jkt 214001
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
E:\FR\FM\10MRN1.SGM
10MRN1
]]>Agencies
[Federal Register Volume 73, Number 47 (Monday, March 10, 2008)]
[Notices]
[Pages 12738-12739]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-4650]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-08-0692]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail
to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of
Management and Budget, Washington, DC or by fax to (202) 395-6974.
Written comments should be received within 30 days of this notice.
Notice of Correction to Burden Table
Proposed Project
A Survey of the Knowledge, Attitudes and Practice of Medical and
Allied Health Professionals Regarding Fetal Alcohol Exposure--
Revision--National Center on Birth Defects and Developmental
Disabilities (NCBDDD), Centers for Disease Control and Prevention
(CDC).
Description of Correction
The previous 30-day Federal Registrar (FRN) published January 25,
2008, Volume 73, No. 17, Pages 4575-4576, was submitted with an error
showing five previously approved forms. This notice is corrected to
show only the requested number of burden hours to continue this
project.
Background and Brief Description
Maternal prenatal alcohol use is one of the leading, preventable,
causes of birth defects and developmental disabilities. Children
exposed to alcohol during fetal development can suffer a wide array of
disorders, from subtle changes in I.Q. and behaviors to profound mental
retardation. These conditions are known as fetal alcohol spectrum
disorders (FASDs). The most severe condition within the spectrum is
fetal alcohol syndrome (FAS), which involves disorders of the brain,
growth retardation, and facial malformations.
Physicians and other health practitioners play a vital role in
diagnosing FAS and in screening women of child-bearing age for alcohol
consumption and drinking during pregnancy. In Diekman's, et al. (2000)
study of obstetricians and gynecologists, only one fifth of doctors
surveyed reported abstinence to be the safest way to avoid the adverse
outcomes associated with fetal alcohol exposure. Importantly, 13% of
doctors surveyed were not sure of levels of alcohol consumption
associated with adverse outcomes. One of CDC's multifaceted initiatives
in combating alcohol-exposed pregnancies is the education and
reeducation of medical and allied health students and practitioners.
In fiscal year 2002, the Centers for Disease Control and Prevention
(CDC) received a congressional mandate to develop guidelines for the
diagnosis of FAS and other conditions resulting from prenatal alcohol
exposure; and to incorporate these guidelines into curricula for
medical and allied health students and practitioners [Public Health
Service Act Section 317K (247b-12) b and c].
In response to the second congressional mandate listed above, CDC
proposed five national surveys of health providers. In August of 2005,
OMB approved these five surveys under control number 0920-0692. The
purposes of the surveys are to assess, among various health care
provider groups, their knowledge, attitudes, and practices regarding
the prevention, identification, and treatment of FASDs. These health
care provider groups are pediatricians, obstetrician-gynecologists (OB-
GYNs), psychiatrists, family physicians, and allied health
professionals.
The results of the surveys will help to inform further development
of model FASD curricula to disseminate among medical and allied health
students and professionals nation wide using a variety of formats
including computer interactive learning applications, workshops and
conferences, Continuing Medical Education credit courses, and medical
and allied health school grand rounds and clerkships. Consistent with
OMB's previous terms of clearance, CDC does not expect the results to
be generalizable to the larger populations of the professional
organizations from which the samples were drawn. Instead, the survey
results will provide necessary information to further develop and
refine educational materials for medical and allied health students and
practitioners and to evaluate their effectiveness. No gifts or
compensation will be given to respondents who complete the survey. An
average of one survey per year will be conducted.
There are no costs to respondents other than their time. The total
estimated annualized burden hours are 375.
Estimated Annualized Burden
----------------------------------------------------------------------------------------------------------------
Average burden per
Type of respondent No. of respondents No. of responses response (in
per respondent hours)
----------------------------------------------------------------------------------------------------------------
Selected Survey Instrument.......................... 900 1 25/60
----------------------------------------------------------------------------------------------------------------
[[Page 12739]]
Dated: February 29, 2008.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E8-4650 Filed 3-7-08; 8:45 am]
BILLING CODE 4163-18-P
